Quantcast

Latest Chronic kidney disease Stories

2014-07-07 16:24:14

NEW YORK, July 7, 2014 /PRNewswire/ -- Mariel Therapeutics, Inc. today announced that it has entered into a definitive agreement to acquire Stryker Corporation's (NYSE: SYK) Bone Morphogenetic Protein-7 (BMP-7) assets for the potential treatment of osteoarthritis (OA), chronic kidney disease (CKD) and other organ fibrosis conditions, lupus, and obesity. Under the terms of the agreement, Mariel acquired the rights to over 450 issued and pending patents, Stryker's BMP-7-related clinical...

2014-07-03 12:25:51

NxStage Patients embrace the flexibility of home hemodialysis to reclaim their lifestyles and live freely LAWRENCE, Mass., July 3, 2014 /PRNewswire/ -- In honor of Independence Day, NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, joins patients across the nation in celebrating the freedom and flexibility they have reclaimed with home hemodialysis (HHD) using the NxStage® System One(TM)....

2014-07-03 11:16:59

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH study suggests people with either should be monitored for both Acute kidney injury (AKI) and chronic kidney disease (CKD) are closely intertwined, with each disease a risk factor for developing the other and sharing other risk factors in common, as well as sharing causes for the diseases to get worse, and outcomes, suggests a comprehensive analysis by scientists at the National Institutes of Health and George...

2014-07-01 16:26:22

After Review of Three Renal Anemia Product Profiles in Development, Expected Use Increases with Disease Severity, According to Findings from Decision Resources Group BURLINGTON, Mass., July 1, 2014 /PRNewswire/ -- Decision Resources Group finds that patient chart data submitted by surveyed nephrologists in China reveals that, consistent with 2011, the percentage of patients on erythropoiesis-stimulating agents (ESAs) significantly increases as chronic kidney disease (CKD) worsens; however,...

2014-06-30 16:26:14

NEW YORK, June 30, 2014 /PRNewswire/ -- According to the National Kidney Foundation, chronic kidney disease affects over 26 million adults in the U.S., and is caused by diabetes and high blood pressure. As kidney functions deteriorate, the kidney's ability to produce red blood cells declines, and results in anemia. Anemia is a condition in which the patient's blood is deficient in red blood cells and hemoglobin. Kidney dialysis is expensive, and the cost of anemia drugs has been...

2014-06-23 08:27:36

Dr. Abdulkareem Alsuwaida joins DaVita team in Saudi Arabia RIYADH, Saudi Arabia, June 23, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it has named Dr. Abdulkareem Alsuwaida, FRCPC, MSc, as chief medical officer for its operations in the Kingdom of Saudi Arabia. "Clinical excellence defines Dr. Alsuwaida's distinctive nephrology career," said Dennis...

2014-06-19 09:49:24

King's College London Heart attack patients with kidney problems may not be getting the full treatment they need, according to a new study led by King's College London. The study found that patients admitted to hospital with chest pains and poorly functioning kidneys are less likely to be given an angiogram and early invasive treatment, which might increase their chance of surviving a heart attack. People admitted to hospital with a suspected heart attack are normally offered early...

2014-06-15 14:57:32

American Society of Nephrology Efforts needed to identify modifiable factors contributing to the higher mortality among black patients Among young adult dialysis patients living in poor neighborhoods, blacks have a significantly higher risk of dying while young compared with whites. The findings, which come from a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN), suggest that more work is needed to understand social factors that could...

2014-06-11 08:30:16

-Special Protocol Assessment for trial design and planned analysis agreed upon by the U.S. Food & Drug Administration PRINCETON, N.J., June 11, 2014 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc., announced today that patient enrollment has begun for a new Phase 3b study of tolvaptan for adult patients with autosomal dominant polycystic kidney disease (ADPKD), the most common, life-threatening, inherited genetic kidney disorder.(1) The company reached an...

2014-06-10 08:29:25

DaVita Rx provides kidney care patients with disease-specific pharmacy alternative DALLAS, June 10, 2014 /PRNewswire-USNewswire/ -- DaVita Rx, a full-service pharmacy created for patients with complex chronic conditions, such as those with kidney disease, announced today that it has filled its 15 millionth prescription since the company's inception in 2005. http://photos.prnewswire.com/prnvar/20140609/116282 DaVita Rx provides specialized services that improve access and adherence...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related